Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 0.52 |
| ▸ | FTH1 | P02794 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | CNR2 | P34972 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24176575 | 1.00 | CYP3A4 (0.52) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| SCHEMBL17857879 | 0.82 | CYP3A4 (0.50) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| SCHEMBL16181033 | 0.74 | CYP3A4 (0.59) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| SCHEMBL17845840 | 0.70 | CYP3A4 (0.51) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL18788522 | 0.69 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL24110118 | 0.69 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL24110084 | 0.69 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL21349931 | 0.69 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| (-)-Caryophyllene Oxide SCHEMBL1532444 | 0.69 | CYP3A4 (1.00) | CYP3A4FTH1CYP2C9CYP2C19CNR2 | |
| SCHEMBL24176164 | 0.69 | CYP3A4 (0.56) | CYP3A4FTH1CYP2C9CYP2C19CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9950982-B2 | 1-(7,10,10-trimethyl-4-bicyclo(6.2.0)decanyl)ethanone as novel aroma chemical | BASF SE (REITSTÖTTER, KINZEBACH & PARTNER) (DE) | 2018-04-24 | — | — | US | disclosed |
| US-20180002266-A1 | 1-(7,10,10-TRIMETHYL-4-BICYCLO(6.2.0)DECANYL)ETHANONE AS NOVEL AROMA CHEMICAL | BASF SE (DE) | 2018-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180002266-A1 | 1-(7,10,10-TRIMETHYL-4-BICYCLO(6.2.0)DECANYL)ETHANONE AS NOVEL AROMA CHEMICAL | OR10J3, TAS2R10, TAS2R50 | CYP3A4 876/4885FTH1 2626/4885CYP2C9 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.